46 results on '"Pal, Karol"'
Search Results
2. Precision immuno-oncology approach for four malignant tumors in siblings with constitutional mismatch repair deficiency syndrome
3. The complete sequence and comparative analysis of ape sex chromosomes
4. Real-World Performance of Integrative Clinical Genomics in Pediatric Precision Oncology
5. Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
6. Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
7. Validation of the EuroClonality-NGS DNA capture panel as an integrated genomic tool for lymphoproliferative disorders
8. LYmphoid NeXt-Generation Sequencing (LYNX) Panel: A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
9. Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1
10. Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trials
11. Transcript Isoform Diversity of Y Chromosome Ampliconic Genes of Great Apes Uncovered Using Long Reads and Telomere-to-Telomere Reference Genome Assemblies
12. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
13. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
14. Integrative NGS testing reveals clonal dynamics of adverse genomic defects contributing to a natural progression in treatment‐naïve CLL patients.
15. Somatic TP53 mutations are preleukemic events in acute lymphoblastic leukemia
16. Somatic TP53 mutations are pre-leukemic events in acute lymphoblastic leukemia
17. Genotyping and Minimal Residual Disease (MRD) Assessment in cfDNA By the Euroclonality-NGS DNA Capture (EC-NDC) Panel in Mantle Cell Lymphoma (MCL)
18. Additional file 1 of Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes
19. Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
20. Consistent B Cell Receptor Immunoglobulin Features Between Siblings in Familial Chronic Lymphocytic Leukemia
21. Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
22. Bioinformatic strategies for the analysis of genomic aberrations detected by targeted NGS panels with clinical application
23. Targeted Next Generation Sequencing Improves Diagnosis in Unclassifiable Leukemic Indolent B-Cell Non-Hodgkin Lymphoma and Identifies a Subset with Recurrent MYD88 Mutations in a Prospective Multicentre Study
24. Recurrent gene mutations detected in canine mast cell tumours by next generation sequencing
25. Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
26. Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
27. Euroclonality-NGS DNA Capture Panel for Integrated Analysis of IG/TR Rearrangements, Translocations, Copy Number and Sequence Variation in Lymphoproliferative Disorders
28. Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants
29. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
30. Quality control and quantification in IG/TR next-generation sequencing marker identification: protocols and bioinformatic functionalities by EuroClonality-NGS
31. Low-burden TP53mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
32. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients
33. CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
34. Prognostic Impact of NOTCH1 Hotspot Mutation in TP53-Mutated Patients with Chronic Lymphocytic Leukemia
35. Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches
36. GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data.
37. Somatic TP53mutations are pre-leukemic events in acute lymphoblastic leukemia
38. A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignant Tumors
39. Tracking low-burden TP53-mutated subclones during CLL treatment and remission using ROR1 separation
40. Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact
41. Prognostic Impact of NOTCH1Hotspot Mutation in TP53-Mutated Patients with Chronic Lymphocytic Leukemia
42. Mutational Analysis of TP53Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches
43. GLASS: assisted and standardized assessment of gene variations from Sanger sequence trace data
44. Complete sequencing of ape genomes.
45. The Complete Sequence and Comparative Analysis of Ape Sex Chromosomes.
46. Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.